The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

https://doi.org/10.1016/0014-2999(95)00846-2Get rights and content

Abstract

Ifenprodil and eliprodil are both non-competitive NMDA receptor antagonists which have been shown to inhibit neuronal Ca2+ channel currents. We have examined the effects of these agents on two defined subtypes of voltage-dependent Ca2+ channels and in the gerbil model of global cerebral ischaemia. Recombinantly expressed human α1B-1α2bβ1–3 Ca2+ subunits in HEK293 cells, which results in an ω-conotoxin-sensitive neuronal N-type voltage-dependent Ca2+ channel and ω-Aga IVA sensitive Ca2+ channels (P-type) in acutely isolated cerebellar Purkinje neurones were reversibly inhibited by ifenprodil and eliprodil. Human N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 μM and 10 μM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 μM and 9 μM respectively. Maximum current block observed for both channel subtypes was approximately 80% for both ifenprodil and eliprodil. For neuroprotection studies, animals were subjected to 5 min bilateral carotid artery occlusion with or without administration of either ifenprodil or eliprodil (5, 10 or 20 mg/kg i.p.) immediately after surgery followed by two further doses (2.5, 5 or 10 mg/kg, respectively) at 3 and 6 h post-occlusion. Both compounds provided significant protective effects against ischaemia-induced neurodegeneration in the CA1 region of the hippocampus. These results indicate that both ifenprodil and eliprodil protect against ischaemia-induced neurodegeneration when administered post-occlusion and that they also block N and P-type voltage-dependent Ca2+ channels.

References (52)

  • M.J. Sheardown et al.

    AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischeamia, even when delayed 24 h

    Eur. J. Pharmacol.

    (1993)
  • S. Toulmond et al.

    Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat

    Existence of a large (18 h) therapeutic window

    Brain Res.

    (1993)
  • R.W. Tsien et al.

    Reflections on calcium channel diversity, 1988–1994

    Trends Neurosci.

    (1995)
  • J.B. Brierley

    Cerebral hypoxia

  • A.M. Buchan et al.

    Hypothermia, but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia

    J. Neurosci.

    (1990)
  • R. Bullock et al.

    Neuroprotective effect of the AMPA receptor antagonist LY 293558 in focal ischemia in the cat

    J. Cereb. Blood Flow Metab.

    (1994)
  • C. Carron et al.

    Synthesis and pharmacological properties of a series of 2 piperidino alkanol derivatives

    Arzneim.-Forsch./Drug Res.

    (1971)
  • C. Carter et al.

    Non-competitive NMDA receptor antagonists acting on the polyamine site

  • D. Choi

    Excitotoxic cell death

    J. Neurobiology

    (1992)
  • J. Church et al.

    Blockade by ifenprodil of high voltage activated calcium channels in rat and mouse cultured hippocampal pyramidal neurones; comparison with NMDA receptor antagonist actions

    Br. J. Pharmacol.

    (1994)
  • D.B. Clissold et al.

    NPC 19377, a potent and selective σ-ligand. II. Behavioural and neuroprotective profile

    J. Pharmacol. Exp. Ther.

    (1993)
  • P. Contreras et al.

    BMY 14802 protects against ischemia-induced neuronal damage in the gerbil

    Life Sci.

    (1992)
  • B.J. Crain et al.

    Selective neuronal death after transient forebrain ishaemia in the Mongolian gerbil: a silver impregnation study

    Neuroscience

    (1988)
  • R. Gill et al.

    The neuroprotective effects of the decahydraisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia

    Neuropharmacology

    (1995)
  • R. Gill et al.

    Systemic administration of MK-801 protects against ischaemia-induced hippocampal neurodegeneration in the gerbil

    J. Neurosci.

    (1987)
  • R. Gill et al.

    MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period

    Neuroscience

    (1988)
  • Cited by (64)

    • Ifenprodil for prolonged spinal blockades of motor function and nociception in rats

      2016, Pharmacological Reports
      Citation Excerpt :

      In in vitro studies, ifenprodil interacts with serotonin (5-hydroxytryptamine; 5-HT) receptors [2] and sigma-1 or sigma-2 receptor [12–14]. As well as binding to those receptors, ifenprodil also blocks G protein-activated inwardly rectifying K+ channels [15], tetrodotoxin-resistant Na+ channels [16], voltage-gated Ca2+ channels [17–19], and Na+/Ca2+ exchanger in neurons [20]. Through blockade of voltage-gated Na+ channels, local anesthetics reversibly inhibit the conduction of electrical impulses in nerves [21,22].

    • Combination therapy of Ifenprodil with Piroxicam may be an effective therapeutic intervention in cerebral stroke: A hypothesis

      2012, Medical Hypotheses
      Citation Excerpt :

      Inhibition of NMDA receptor channels by ifenprodil is thought to have important implications in these therapeutic effects [34]. It has also been shown that ifenprodil interacts with several other receptors, namely, serotonin (5-hydroxytryptamine; 5-HT) subtype 1A, 5-HT2 and 5-HT3 receptors [18,35], and s receptors [36] at nanomolar concentrations and that it inhibits voltage-gated Ca2+ channels at micromolar concentrations [37,38]. These effects might also be involved in the molecular mechanisms underlying some of the therapeutic effects and side effects of ifenprodil.

    • Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation

      2008, Progress in Brain Research
      Citation Excerpt :

      Another approach is to focus on the increased influx of calcium caused by the excess of glutamate and the hyperstimulation of voltage-gated calcium channels (Choi, 1988a, b). Indeed, some calcium channel blockers have been shown to reduce retinal damage (Takahashi et al., 1992; Bath et al., 1996). Neurotrophins are crucial for the normal maintenance of the CNS.

    View all citing articles on Scopus
    View full text